These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11723766)

  • 21. Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis.
    van Rossum AP; Limburg PC; Kallenberg CG
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S64-8. PubMed ID: 14740429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
    Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
    J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides].
    Guilpain P; Chanseaud Y; Tamby MC; Mahr A; Servettaz A; Guillevin L; Mouthon L
    Presse Med; 2005 Aug; 34(14):1013-22. PubMed ID: 16225257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis?
    van Paassen P; Tervaert JW; Heeringa P
    Nephron Exp Nephrol; 2007; 105(1):e10-6. PubMed ID: 17108705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Heeringa P; Tervaert JW
    Kidney Int; 2004 May; 65(5):1564-7. PubMed ID: 15086893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies.
    Reumaux D; Duthilleul P; Roos D
    Hum Immunol; 2004 Jan; 65(1):1-12. PubMed ID: 14700590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
    Jennette JC; Xiao H; Falk RJ
    J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade.
    Hayes MJ; Cambridge G
    Mol Immunol; 2004 Jun; 41(4):457-68. PubMed ID: 15163542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
    Xin G; Zhao MH; Wang HY
    Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dual-fixed neutrophil substrate improves interpretation of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
    Lin MW; Silvestrini RA; Culican S; Campbell D; Fulcher DA
    Am J Clin Pathol; 2014 Sep; 142(3):325-30. PubMed ID: 25125622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Shuai ZW; Lv YF; Zhang MM; Hu ZY
    Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitope-specific anti-neutrophil cytoplasmic antibodies: do they matter? Can they be detected?
    Specks U
    APMIS Suppl; 2009 Jun; (127):63-6. PubMed ID: 19515143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANCA-Associated Vasculitis Pathogenesis: A Commentary.
    Gapud EJ; Seo P; Antiochos B
    Curr Rheumatol Rep; 2017 Apr; 19(4):15. PubMed ID: 28361331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro.
    Weidner S; Neupert W; Goppelt-Struebe M; Rupprecht HD
    Arthritis Rheum; 2001 Jul; 44(7):1698-706. PubMed ID: 11465722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models.
    Huugen D; Tervaert JW; Heeringa P
    Curr Opin Rheumatol; 2004 Jan; 16(1):4-8. PubMed ID: 14673382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells.
    Pendergraft WF; Alcorta DA; Segelmark M; Yang JJ; Tuttle R; Jennette JC; Falk RJ; Preston GA
    Kidney Int; 2000 May; 57(5):1981-90. PubMed ID: 10792617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.